Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Br J Dermatol. 2011 Nov 2;165(6):1219–1222. doi: 10.1111/j.1365-2133.2011.10551.x

TABLE 1. CDKN2A/CDK4 mutations detected in 17 Greek melanoma patients.

Gene Site Nucleotide position Effect on
p16/ARF
CDKN2A/CDK4
Mutations
(n=17)
CDKN2A Exon
−34G>C* Not known/
Presumably none
1 SPM
CDKN2A Exon
−25C>T Not known/
Presumably none
1 SPM
CDKN2A Exon
c.71G>C p.R24P/none 5 SPM
3 MPM
CDKN2A Exon
c.41-
43delinsCCGTGGCTGGCCACGGCCAC*
Frameshift 1 MPM+FM
CDKN2A Exon 2 c.259C>T p.R87W/p.P142L 1 SPM
CDKN2A Exon 2 c.301G>C* p.G101R/p.R156P 1 FM
CDKN2A Exon 2 c.302G>A* p.G101E/none 1 SPM
CDKN2A Exon 2 c.330G>A p.W110X/p.G125R 1 MPM
CDKN2A Exon 2 c.296_297insGACC* Frameshift 1 SPM
CDK4 Exon2 c.71G->A p.R24H (Cdk4) 1 FM
*

Novel mutations